Ge Healthcare Technologies INC Form 4 insider transactions

CEO of Imaging, Roland Rott, reports acquisition of restricted stock units and employee stock options in GE HealthCare Technologies Inc.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports the acquisition of stock options and restricted stock units in the company.

Peter Arduini, CEO of GE HealthCare Technologies Inc., reports acquisition of shares and stock options in a recent SEC filing.

Chief People Officer Adam Y. Holton reports the acquisition of restricted stock units and an employee stock option in GE HealthCare Technologies Inc.

Chief Technology Officer Taha Kass-Hout reports acquisition of restricted stock units and employee stock options in GE HealthCare Technologies Inc.

Thomas J. Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Peter Arduini, CEO of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted and performance stock units.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., sold 2,000 shares of common stock at a price of $92.54 per share on February 18, 2025.

Peter Arduini, CEO of GE HealthCare Technologies Inc., reports the acquisition and disposal of common stock related to performance stock units (PSUs) that vested following the satisfaction of performance criteria.

James Saccaro, CFO of GE HealthCare Technologies Inc., disposed of shares to satisfy tax withholding obligations related to vesting restricted stock units.

CEO of Imaging at GE HealthCare Technologies, Roland Rott, disposed of 558 shares of common stock to cover tax obligations related to vesting restricted stock units.

Thomas J. Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., sold 158 shares of common stock to cover tax obligations related to vesting restricted stock units.

Peter J. Arduini, a director and the President and CEO of GE HealthCare Technologies Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., reports the withholding of 444 common stock shares to cover tax obligations related to vesting restricted stock units on February 1, 2025.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., exercised employee stock options and sold a portion of the acquired shares to cover the exercise price and tax obligations.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., sold 900 shares of common stock on November 5, 2024.

Kenneth R. Stacherski, Chief Supply Chain & Service Officer of GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Philip Rackliffe, CEO of Ultrasound & IGT at GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., reports the withholding of 685 shares to cover tax obligations related to vesting restricted stock units on September 1, 2024.

James Saccaro, CFO of GE HealthCare Technologies Inc., sold 1,740 shares of common stock on September 1, 2024, to cover tax obligations related to vesting restricted stock units.

Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., reports the withholding of 458 shares to cover tax obligations related to vesting restricted stock units.